Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences